Johanna Ell

Johanna Ell

Auto-generated profile, based on publicly available information

Johanna Ell

Department of Psychiatry and Psychotherapy, Medical Center—University of Freiburg, Faculty of Medicine University of Freiburg Freiburg Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2024 in Journal of Sleep Research
Verified
Journal Article
Open access
JEJohanna Ell
Johanna Ell
HBHanna A. Brückner
Hanna A. Brückner
AJAnna F. Johann
Anna F. Johann
LSLisa Steinmetz
Lisa Steinmetz
LGLara J. Güth
Lara J. Güth
KSKai Spiegelhalder
Kai Spiegelhalder
Summary: Insomnia is a primary symptom of shift work disorder, yet it remains undertreated. This randomised‐controlled pilot trial examined the efficacy of a digital, guided cognitive behavioural therapy for insomnia adapted to shift work (SleepCare) in nurses with shift work disorder. The hypothesis was that SleepCare reduces insomnia severity compared with a waitlist control condition. A total of 46 unmedicated nurses suffering from shift work disorder with insomnia (age: 39.7 ± 12.1 years; 80.4% female) were randomised to the SleepCare group or the waitlist control group. The primary outcome measure was the Insomnia Severity Index. Other questionnaires on sleep, mental health and occupational functioning, sleep diary data and actigraphy data were analysed as secondary outcomes. Assessments were conducted before (T0), after the intervention/waitlist period (T1), and 6 months after treatment completion (T2). The SleepCare group showed a significant reduction in insomnia severity from T0 to T1 compared with the control condition (β = −4.73, SE = 1.12, p < 0.001). Significant improvements were observed in sleepiness, dysfunctional beliefs about sleep, pre‐sleep arousal, sleep effort, self‐reported sleep efficiency and sleep onset latency. No significant effect was found in actigraphy data. Depressive and anxiety symptoms, cognitive irritation and work ability improved significantly. Overall, satisfaction and engagement with the intervention was high. SleepCare improved insomnia severity, sleep, mental health and occupational functioning. This is the first randomised‐controlled trial investigating the efficacy of digital cognitive behavioural therapy for insomnia in a population suffering from shift work disorder with insomnia. Future research should further explore these effects with larger sample sizes and active control conditions.

1 August 2023 in Journal of Sleep Research
Verified
Journal Article
Open access
JEJohanna Ell
Johanna Ell
SSSarah R. Schmid
Sarah R. Schmid
FBFee Benz
Fee Benz
LSLukas Spille
Lukas Spille
Summary: Insomnia is a common disorder and cognitive behavioural therapy for insomnia (CBT‐I) is recommended as first‐line treatment. However, CBT‐I is not widely distributed and infrequently available while medication is not indicated for long‐term use. To close this evident gap in supply, alternative treatments could be utilised. High‐quality research on this topic is scarce, and there is currently no comprehensive publication on the effectiveness of alternative treatments. To address this pressing question, we systematically summarised the existing research on alternative treatments for insomnia. A comprehensive search of systematic reviews and (network) meta‐analyses of randomised controlled trials investigating the efficacy of alternative treatments compared to waiting‐list control or placebo in adults with insomnia disorder with or without comorbidities was conducted in PubMed, MEDLINE, PsycInfo, and PsycArticles on December 6, 2022, yielding 391 records. Finally, 15 eligible studies were included. Evidence on acupuncture, exogenous melatonin, mind–body interventions and exercise, repetitive transcranial magnetic stimulation (rTMS), valerian, and light exposure was found. Acupuncture, rTMS and mind–body exercises significantly improved sleep quality and insomnia severity but effects on objectively assessed outcomes were inconclusive. Melatonin led to a reduction in both self‐reported and objectively assessed sleep onset latency. Light exposure and valerian did not significantly improve sleep outcomes. Overall, the quality of studies was rated as low. Results indicate that alternative treatments are effective mostly on subjective outcomes. However, evidence on the efficacy of some intervention types is sparse and there is a need for high‐quality original studies. Future research could investigate whether combining different alternative treatment aspects with CBT‐I improves individual treatment.

2 April 2023 in SLEEP
Verified
Journal Article
Closed access
PDF file
JEJohanna Ell
Johanna Ell
JSJulian E Schiel
Julian E Schiel
BFBernd Feige
Bernd Feige
DRDieter Riemanm
Dieter Riemanm
CNCasandra Caroline Nyhuis
Casandra Caroline Nyhuis
KSKai Spiegelhalder
Kai Spiegelhalder
The long-term effects of sleep health and shift work on cognitive performance are unclear. In addition, research has been limited by small sample sizes and short follow-up periods. We conducted one of the largest examinations of the longitudinal influence of sleep health dimensions and shift work on cognitive performance in people of middle and old age using data from the UK Biobank. The hypothesis was that poor sleep health and shift work would predict lower cognitive performance. Self-reported sleep duration, daytime sleepiness, insomnia symptoms, chronotype and shift work status were assessed as predictors at baseline. Cognitive performance was operationalised by a touchscreen test battery at follow-up between 7.4 ± 2.2 and 9.0 ± 0.9 years after baseline assessment, depending on the specific task. Models were performed for each cognitive domain including relevant confounders (e.g., depression). The alpha level was set at p<0.01 for all analyses. The study sample comprised 9,394 participants for the reasoning task, 30,072 for the reaction time task, 30,236 for the visual memory task, 2,019 for the numeric memory task and 9,476 for the prospective memory task. Shift work without night shifts (ß= -2.0x10- 1 ± 6.5x10- 2, p=0.002) and with night shifts (ß= -1.9x10- 1 ± 7.2x10- 2, p=0.010) predicted a significantly reduced performance in the reasoning task. Short sleep duration (ß= -2.4x10- 1 ± 7.9x10- 2, p=0.003) and shift work without night shifts (ß= -3.9x10- 1 ± 1.2x10- 1, p=0.002) predicted a significantly lower performance in the task probing prospective memory. Our results suggest that, after controlling for confounding variables, shift work and short sleep duration are important predictors for cognitive performance in people of middle and old age. Further work is required to examine causal mechanisms of the observed associations.

Verified
Journal Article
Open access
PDF file
MSMarcin Sochal
Marcin Sochal
BFBernd Feige
Bernd Feige
KSKai Spiegelhalder
Kai Spiegelhalder
JEJohanna Ell
Johanna Ell
Background: Sleep and physical activity (PA) are bidirectionally related, with PA having a positive effect on sleep, and sleep quality influencing PA the following day. However, little is known about the effects of clinical interventions for sleep disorders on PA. Therefore, the aim of this secondary analysis is to evaluate the impact of cognitive behavioral therapy for insomnia (CBT-I), the first-line treatment for insomnia, on PA. Methods: Thirty-eight nurses with shift work disorder and insomnia were randomly assigned to either CBT-I or a waitlist control group. PA was measured for one week before (T0) and after the intervention/waiting period (T1) using actigraphy and sleep diary items. The impact of CBT-I on the PA parameters was analyzed using linear mixed models. In addition, correlations of pre-to-post-treatment changes in PA and pre-to-post-treatment changes in the clinical outcomes (insomnia severity, sleep efficiency, depression) were explored in the CBT-I group. Results: CBT-I increased actigraphy-derived PA during the two hours (β = 26.17, SE = 9.41, p = 0.009) and one hour (β = 13.24, SE = 4.57, p = 0.006) after time in bed, and resulted in a higher percentage of self-reported days with PA (β = 19.11, SE = 9.36, p = 0.049) compared to the waitlist control group. No significant correlations were found between the changes in PA and clinical outcomes, except for a moderate positive correlation between changes in self-reported sleep efficiency and changes in PA one hour before time in bed (r = 0.56, p = 0.013). Conclusions: This is the first study to investigate the impact of CBT-I on PA, providing preliminary evidence of the potential positive effects. Further studies with larger sample sizes and randomized controlled designs with continuous PA monitoring are needed to confirm these preliminary results.

3 February 2021 in Somnologie
Verified
Journal Article
Closed access
PDF file
JEJohanna Ell
Johanna Ell
FBFee Benz
Fee Benz
NWNatasza Walter
Natasza Walter
LSLisa Steinmetz
Lisa Steinmetz
HBHanna Brückner
Hanna Brückner
KSKai Spiegelhalder
Kai Spiegelhalder

4 June 2026 in Journal of Sleep Research
Verified
Journal Article
Open access
SSSarah R. Schmid
Sarah R. Schmid
CBChristine Blume
Christine Blume
JEJohanna Ell
Johanna Ell
NKNikolas Konzen
Nikolas Konzen
MAMatthias Apweiler
Matthias Apweiler
KSKai Spiegelhalder
Kai Spiegelhalder
Cognitive behavioural therapy for insomnia (CBT‐I) is recommended as first‐line treatment for insomnia disorder. However, around 25% of the patients do not respond to the treatment, and only 40% achieve full remission. The current study investigates the therapeutic potential of light therapy as an add‐on to CBT‐I. Insomnia severity and questionnaire‐related secondary outcomes were assessed at baseline, post‐treatment and follow‐up. Sleep diary‐related variables and the cortisol awakening response were assessed at pre‐ and post‐treatment. Linear mixed models were calculated for each outcome variable. The study included 42 patients with insomnia disorder. Reduction in insomnia severity did not significantly differ between groups from baseline to post‐treatment ( β = 0.35, SE = 1.31, p = 0.792). Regarding exploratory secondary outcomes, daytime sleepiness was significantly more reduced from baseline to follow‐up in the CBT‐I + light therapy group than in the CBT‐I + placebo light group ( β = −1.05, SE = 0.43, p = 0.020). There was no significant condition × time point interaction effect for any of the other secondary outcomes. The findings show no significant add‐on effect of light therapy on insomnia severity. However, light therapy had a significant effect on daytime sleepiness that became evident only at the follow‐up. Given that daytime functioning is of high clinical relevance for patients with insomnia disorder, daytime sleepiness should be further evaluated as treatment target and may be addressed with light therapy. Trial Registration: ClinicalTrials.gov identifier: DRKS00029640